The narcotic-dependent mother: Fetal and neonatal consequences
References (30)
- et al.
The effects of maternal narcotic addiction on the newborn
Am. J. Obstet. Gynecol.
(1956) Drug addiction in pregnant women
Am. J. Obstet. Gynecol.
(1967)- et al.
The course of the heroin withdrawal syndrome in newborn infants treated with phenobarbital or chlorpromazine
J. Pediatr.
(1969) - et al.
Heroin addiction during pregnancy
Am. J. Obstet. Gynecol.
(1972) - et al.
Methadone withdrawal in newborn infants
J. Pediatr.
(1972) - et al.
Clinical assessment of gestational age in the newborn infant
J. Pediatr.
(1970) - et al.
Pharmacologic observations on the neonatal withdrawal syndrome
J. Pediatr.
(1976) - et al.
Absence of respiratory distress syndrome in premature infants of heroin-addicted mothers
Lancet
(1971) - et al.
Narcotic withdrawal in pregnancy: Stillbirth incidence with a case report
Am. J. Obstet. Gynecol.
(1973) - et al.
Heroin addiction among pregnant women and their newborn babies
Am. J. Obstet. Gynecol.
(1958)
The effect of maternal narcotic addiction on the newborn infant; review of literature and report of 22 cases
Pediatrics
Neonatal narcotic addiction: 10 year observation
Pediatrics
Observations on heroin and methadone withdrawal in the newborn
Pediatrics
Newborn infants of mothers on mothadone maintenance
N.Y. State J. Med.
The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants
Pediatrics
Cited by (147)
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome
2019, Clinics in PerinatologyNo. 349-Substance Use in Pregnancy
2017, Journal of Obstetrics and Gynaecology CanadaN<sup>o</sup> 349 – Consommation de substances psychoactives pendant la grossesse
2017, Journal of Obstetrics and Gynaecology CanadaCitation Excerpt :La méthadone est un agoniste pur dont l'effet augmente avec la dose. Les avantages de son administration pendant la grossesse sont nombreux : amélioration des soins prénataux75,92–94, gestation prolongée29,95, augmentation du poids à la naissance96,97, hausse de la proportion d'enfants confiés aux soins de leur mère28,75,86,93,98–105, etc. Même si les nouveau-nés dont la mère recevait de la méthadone ont tendance à être plus petits (poids à la naissance, taille, circonférence de la tête) que ceux non exposés à des drogues, des études ont montré que l'écart de croissance était comblé à l'âge de 12 mois105,106.
Infants Born to Opioid-Dependent Women in Ontario, 2002–2014
2017, Journal of Obstetrics and Gynaecology CanadaCitation Excerpt :Compared with the outcomes in unexposed infants, prenatal opioid exposure is associated with adverse perinatal outcomes and increased health care costs.3 Placental transmission of illicit opioids and opioid agonist therapies such as methadone and buprenorphine leads to fetal dependence and neonatal withdrawal (neonatal abstinence syndrome).4 NAS affects neonatal adaptation in critical areas of sleep, feeding, and autonomic function.5,6
- ∗
Currently Chief, Division of Neonatology, Beth Israel Medical Center, 10 Nathan D. Perlman Place, New York, N.Y. 10003, U.S.A.